glp-1 and mash MASH: When weight loss isn't the whole story What is becoming the #1

The drug, along with others like Wegovy and Mounjaro a tirzepatide active ingredient medication, is creating a buzz in Hollywood, leading to both hype and concerns

All of the conditions in blue below indicate signficant reductions in risk for those taking GLP-1 drugs compared to usual care (indicated by hazard ratios that are less than 1, so to the left of the dotted line)

Topical GHK-Cu is generally well tolerated, but some people may experience mild scalp irritation, redness, itching, or contact dermatitis

Mitochondria in neuroinflammationMultiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS